The Complete Diabetes & GLP-1 Clinical Bundle - 2 Practical Medical Books | 2026/2027
π THE ULTIMATE DIABETES & GLP-1 CLINICAL MASTERCLASS BUNDLE
2026β2027 | Expanded Edition
TWO COMPREHENSIVE MEDICAL eBOOKS | APPROXIMATELY 312 PAGES | ONE COMPLETE CLINICAL LEARNING EXPERIENCE!
π THE COMPLETE CLINICAL DIABETES CASEBOOK β 2026β2027 Expanded Edition
269 Pages | 61 Clinical Cases | 12 Comprehensive Sections
π THE COMPLETE PRACTICAL GUIDE TO GLP-1 RECEPTOR AGONISTS β 2026β2027 Edition
Approximately 43 Pages | Practical Dosing, Clinical Cases & Landmark Trials
π― FROM GUIDELINES TO REAL CLINICAL PRACTICE!
Are you an Internal Medicine Specialist, Endocrinologist, Diabetologist, General Practitioner, or healthcare professional looking to master practical diabetes management, insulin therapy, obesity treatment, and modern GLP-1-based medications?
This exclusive bundle combines two comprehensive, evidence-informed medical eBooks designed to bridge the gap between theoretical knowledge and everyday clinical decision-making.
More than just textbooks β a structured, course-style learning experience built around real-world clinical practice.
π BOOK 1: THE COMPLETE CLINICAL DIABETES CASEBOOK
2026β2027 Expanded Edition | 269 Pages | 61 Cases | 12 Sections
A Complete Case-Based Guide to Modern Diabetes Management
This expanded edition takes you step by step from patient presentation and diagnostic reasoning to treatment selection, insulin dose calculations, medication titration, monitoring, and follow-up.
WHAT WILL YOU LEARN?
π©Έ 1. TYPE 1 DIABETES MELLITUS
- Newly diagnosed Type 1 Diabetes
- Basalβbolus insulin initiation
- Total Daily Dose (TDD) calculations
- Insulin-to-Carbohydrate Ratio (ICR)
- Insulin Sensitivity Factor (ISF)
- Meal bolus and correction dose calculations
- Honeymoon phase
- Exercise-related hypoglycemia
- Sick-day management and ketone monitoring
- Continuous Glucose Monitoring (CGM)
- Insulin pumps and Automated Insulin Delivery (AID)
- Type 1 Diabetes with advanced CKD
π 2. TYPE 2 DIABETES MELLITUS
- Initial monotherapy versus dual therapy
- Rational triple therapy
- Choosing the most appropriate glucose-lowering medications
- Type 2 Diabetes with obesity
- Diabetes with albuminuric CKD
- Diabetes with cardiovascular disease
- Basal insulin initiation and titration
- Basal-plus and basalβbolus intensification
- GLP-1-based treatment strategies
- Hypoglycemia management in older adults
- Dyslipidemia and cardiovascular risk reduction
𧬠3. OTHER TYPES OF DIABETES & EMERGENCIES
- Latent Autoimmune Diabetes in Adults (LADA)
- MODY 2, MODY 3, and HNF1B-MODY
- Gestational Diabetes Mellitus (GDM)
- Steroid-induced hyperglycemia
- Pancreatogenic Diabetes (Type 3c)
- Severe hypoglycemia
- Diabetic Ketoacidosis (DKA)
- Hyperosmolar Hyperglycemic State (HHS)
- Euglycemic DKA associated with SGLT2 inhibitors
π¬ 4. WHEN HbA1c IS MISLEADING
Learn how to recognize falsely elevated or falsely reduced HbA1c in:
- Iron-deficiency anemia
- Hemolytic anemia
- Hemoglobinopathies
- Chronic kidney disease and dialysis
- Recent blood transfusion
- Pregnancy
- Hypoalbuminemia
Includes practical diagnostic alternatives and an HbA1c discordance algorithm.
π§ 5. DIABETES INSIPIDUS
- Central Diabetes Insipidus
- Nephrogenic Diabetes Insipidus
- Postoperative Diabetes Insipidus
- Lithium-induced nephrogenic DI
- Primary polydipsia versus DI
- Post-traumatic Diabetes Insipidus
π 6. ADVANCED INSULIN THERAPY
- Once-weekly basal insulin
- Emerging weekly insulin combinations
- Practical prescribing considerations
- Treatment selection and monitoring
π 7. NEW DIABETES MEDICINES OF 2026
- Orforglipron (Foundayo)
- Oral semaglutide formulations
- Wegovy pill
- Ozempic pill
- Newer oral glucose-lowering agents
- Medication titration and switching
- Renal and hepatic considerations
- Drug interactions and safety monitoring
π§ͺ 8. IMMUNOTHERAPY IN TYPE 1 DIABETES
- Type 1 Diabetes staging
- Autoantibody screening
- Teplizumab (Tzield)
- Beta-cell preservation
- Emerging monoclonal antibody therapies
- Clinical applications and future developments
π§« 9. BETA-CELL REPLACEMENT
- Islet cell transplantation
- Pancreas transplantation
- Simultaneous pancreasβkidney transplantation
- Patient selection and clinical considerations
π¦Ά 10. DIABETIC NEUROPATHY β COMPLETE DRUG GUIDE
- Painful diabetic peripheral neuropathy
- Mirogabalin
- Pregabalin and gabapentin
- Duloxetine
- Alternative and combination therapies
- Renal and hepatic dose adjustments
- Topical capsaicin
- Autonomic neuropathy
- Gastroparesis and orthostatic hypotension
π₯ 11. NUTRITION, MEAL PLANNING & EXERCISE
- Medical Nutrition Therapy
- Carbohydrate counting
- Seven-day meal plans
- Nutrition in Type 1 and Type 2 Diabetes
- Diabetes with CKD, heart failure, obesity, and MASLD
- Ramadan considerations
- Exercise prescriptions
- Insulin adjustments during physical activity
π‘ 12. OPTOGENETICS & TAKE-HOME CLINICAL MESSAGES
- Light-responsive insulin-producing cells
- Experimental optogenetic technologies
- Future approaches to Type 1 Diabetes
- Experimental approaches to diabetic neuropathy
- Insulin dosing quick-reference tables
- Medication titration ladders
- Renal and hepatic dose-adjustment tables
- Emergency management principles
- Practical clinical checklists
WHAT MAKES THIS BOOK DIFFERENT?
Each clinical case follows a structured approach:
Patient Presentation β Investigations β Diagnostic Reasoning β Treatment Selection β Dose Calculations β Monitoring β Follow-Up
With practical clinical pearls, medication tables, generic and trade names, and important safety considerations.
π BOOK 2: THE COMPLETE PRACTICAL GUIDE TO GLP-1 RECEPTOR AGONISTS
Evidence-Based Clinical Handbook | 2026β2027 Edition
Approximately 43 Pages
A Focused Clinical Guide to Modern Diabetes and Obesity Pharmacotherapy
Explore the science, clinical applications, practical prescribing, and major evidence behind GLP-1-based therapies.
WHAT WILL YOU LEARN?
𧬠GLP-1 PHYSIOLOGY & MECHANISMS
- GLP-1 receptor physiology
- Glucose-dependent insulin secretion
- Glucagon suppression
- Appetite regulation
- Gastric emptying
- Weight reduction and metabolic effects
π COMPREHENSIVE MEDICATION GUIDE
- Semaglutide
- Liraglutide
- Dulaglutide
- Exenatide
- Lixisenatide
- Tirzepatide
- Retatrutide (investigational)
- Emerging incretin-based therapies
π PRACTICAL PRESCRIBING & TITRATION
- Choosing the appropriate GLP-1-based therapy
- Starting doses
- Dose escalation schedules
- Switching between medications
- Managing gastrointestinal adverse effects
- Contraindications and precautions
- Renal and hepatic considerations
- Monitoring treatment response
- Managing inadequate glycemic or weight response
βοΈ GLP-1 THERAPIES IN SPECIAL POPULATIONS
- Type 2 Diabetes
- Obesity and weight management
- Cardiovascular disease
- Chronic kidney disease
- Metabolic liver disease
- Patients receiving insulin
- Complex patients with multiple comorbidities
π LANDMARK CLINICAL TRIALS
- STEP
- SUSTAIN
- SELECT
- FLOW
- LEADER
- REWIND
- SURPASS
- SURMOUNT
Learn how major clinical trials inform treatment decisions and the selection of incretin-based therapies.
π©Ί PRACTICAL CLINICAL APPLICATIONS
- Clinical case discussions
- Practical medication tables
- Common prescribing mistakes
- Clinical pearls
- Frequently asked questions
- Follow-up and monitoring strategies
π WHY GET BOTH BOOKS?
The Diabetes Casebook teaches you how to manage diabetes through practical clinical cases.
The GLP-1 Handbook helps you understand and prescribe modern incretin-based therapies.
Together, they cover:
β Diabetes diagnosis and classification
β Type 1 and Type 2 Diabetes management
β Insulin calculations and dose adjustments
β Monotherapy, dual therapy, and triple therapy
β Diabetes emergencies and complications
β GLP-1 and dual GIP/GLP-1 therapies
β Obesity and metabolic disease management
β Cardiovascular and renal considerations
β Medication titration and monitoring
β Landmark clinical trials
β Emerging diabetes treatments
β Evidence-informed clinical decision-making
π¨ββοΈ WHO IS THIS BUNDLE FOR?
- Internal Medicine Residents and Specialists
- Endocrinologists and Diabetologists
- General Practitioners
- Family Medicine Physicians
- Clinical Nutrition Professionals
- Physicians preparing for postgraduate examinations
- Healthcare professionals interested in diabetes, obesity, and metabolic medicine
π¦ WHAT WILL YOU RECEIVE?
π Book 1: The Complete Clinical Diabetes Casebook β 269 Pages
π Book 2: The Complete Practical Guide to GLP-1 Receptor Agonists β Approximately 43 Pages
π TOTAL: APPROXIMATELY 312 PAGES
π₯ Format: Two Digital PDF eBooks
π Language: English
π Edition: 2026β2027
βοΈ Author: Dr. Abdullah Aboelkheir
Internal Medicine Specialist
Master's Degree in Internal Medicine β Al-Azhar University
π TWO BOOKS. ONE COMPLETE CLINICAL LEARNING EXPERIENCE!
From understanding diabetes to making practical treatment decisions and exploring modern GLP-1-based therapies.
Whether you're managing newly diagnosed diabetes, calculating insulin doses, selecting advanced glucose-lowering medications, or treating patients with obesity, cardiovascular disease, and chronic kidney disease, this bundle is designed to help you connect clinical evidence with real-world practice.
π Learn the principles.
π©Ί Understand the clinical cases.
π Master the practical treatment approach.
π― FROM GUIDELINES TO PRACTICE!